首页> 外文期刊>Urology >Volume-weighted mean nuclear volume in renal cell carcinoma.
【24h】

Volume-weighted mean nuclear volume in renal cell carcinoma.

机译:肾细胞癌的体积加权平均核体积。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: Tumor grade and stage are the most important prognostic parameters for renal cell carcinoma (RCC). The value of histologic nuclear grading, however, is impaired by the inconsistency of pathologists' observations. Estimate of volume-weighted mean nuclear volume (MNV), based on a stereologic method, is correlated with prognosis of bladder, prostate, and endometrial cancer. In this study, we investigated the prognostic value of stereologic estimation of nuclear volume in RCC. METHODS: This study included 62 patients with RCC who underwent radical nephrectomy between 1989 and 1996. Patients were evaluated in two groups: patients with locally advanced and/or metastatic disease were part of the poor prognosis group and patients with localized disease were part of the good prognosis group. Unbiased estimates of MNV were compared with histologic grade, tumor stage, and growth pattern according to Thoenes classification. Group means were compared using the nonparametric Kruskal-Wallis one-way analysis of variance. Univariate analysis of the data was performed for MNV and time to death, metastasis, local recurrence, and disease-free survival by paired sample t test. For categorical variables, Pearson's correlation test was used for statistical analysis. RESULTS: There was no correlation between MNV and patient sex, age, tumor stage, and growth pattern. MNV showed a trend to be higher in sarcomatoid and chromophilic cell types than in chromophobe and clear cell types (P < 0.05). MNV values were significantly higher with increasing grades but no MNV cutoff levels could be defined. The MNV values were not different between localized and locally advanced and/or metastatic disease. CONCLUSIONS: Our results indicate that estimates of MNV are not useful for predicting disease outcome. Further studies are needed to set up reproducible intervals of tumor dedifferentiation that could be carried out in routine practice for predicting progression.
机译:目的:肿瘤的分级和分期是肾细胞癌(RCC)最重要的预后参数。但是,病理学家的观察结果不一致会损害组织学核分级的价值。基于体视学方法的体积加权平均核体积(MNV)估计与膀胱癌,前列腺癌和子宫内膜癌的预后相关。在这项研究中,我们调查了RCC核体积的体视学估计的预后价值。方法:本研究包括1989年至1996年间接受根治性肾切除术的62​​例RCC患者。将患者分为两组:预后不良组为局部晚期和/或转移性疾病患者,预后不良组为局部疾病患者。预后好组。根据Thoenes分类,将MNV的无偏估计与组织学等级,肿瘤分期和生长方式进行了比较。使用非参数Kruskal-Wallis单向方差分析比较组均值。通过配对样本t检验对MNV以及死亡,转移,局部复发和无病生存时间进行数据单变量分析。对于分类变量,将Pearson相关检验用于统计分析。结果:MNV与患者的性别,年龄,肿瘤分期和生长方式之间无相关性。在肉瘤样细胞和嗜铬细胞类型中,MNV的趋势高于发色细胞和透明细胞类型(P <0.05)。随着等级的增加,MNV值明显更高,但是无法定义MNV截止水平。在局部和局部晚期和/或转移性疾病之间,MNV值没有差异。结论:我们的结果表明,MNV的估计对预测疾病的结果没有用。需要进行进一步的研究以建立可再现的肿瘤脱分化间隔,该间隔可在常规实践中用于预测进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号